Snisarenko John 4
4 · Oyster Point Pharma, Inc. · Filed Sep 24, 2021
Insider Transaction Report
Form 4
Snisarenko John
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-09-22+20,000→ 20,000 totalExercise: $12.23Exp: 2031-09-21→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Option granted on September 22, 2021 under the Oyster Point Pharma, Inc. 2019 Equity Incentive Plan. 1/4th of the options shall vest and become exercisable on August 25, 2022 and one thirty-sixth (1/36) of the remaining options shall vest monthly thereafter on the same day of the month (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2019 Equity Incentive Plan) through each such date.